Google Alert - "Myeloproliferative neoplasms" OR "polycythemia vera" OR myelofibrosis OR "essential thrombocythemia" google.com

Understanding <b>Myelofibrosis</b> and the Central Role of JAK Pathway Dysregulation

google.com·21w

Atavistik Bio Holds $120 Million Series B Financing to Advance Small Molecule Therapies ...

google.com·21w

Patient Engagement and Self-Efficacy Are Key to MF Self-Care, Study Finds

google.com·22w

Oncology Pharmacists Discuss Role of JAK Inhibitors and Anemia Management in ...

google.com·22w

JAK Inhibitors Target Dysregulated Pathway to Manage Anemia in <b>Myelofibrosis</b>

google.com·22w

Atavistik Bio Raises $120 Million Series B Financing to - GlobeNewswire

google.com·22w

Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

google.com·22w

Regeneron backs Atavistik&#39;s $120M raise to advance small molecule pair

google.com·22w

David Steensma: Ajax Therapeutics Receives Orphan Drug Designation by FDA for AJ1 ...

google.com·22w

Eilean&#39;s ZE74-0282 set to enter clinic for <b>myelofibrosis</b> | BioWorld

google.com·22w

EC Approves Label Expansion of INCY&#39;s Lymphoma Drug Minjuvi - TradingView

google.com·22w

Atavistik Bio Raises $120 Million Series B Financing to Advance the Development of ... - BioSpace

google.com·22w

Interferon Therapy Improves Survival in Early <b>Myelofibrosis</b> - Hematology Advisor

google.com·22w

Atavistik Bio Raises $120 Million Series B Financing to Advance the Development of ...

google.com·22w

Eilean Therapeutics Advances ZE74-0282, a Highly Selective Inhibitor of Mutated JAK2 ...

google.com·22w

Rusfertide Demonstrates Durable Hematocrit Control and Symptom Improvement for ...

google.com·22w

Eilean Therapeutics Advances ZE74-0282, a Highly Selective Inhibitor of Mutated JAK2 ...

google.com·22w

Piper Sandler names Karyopharm stock as 2026 top pick, maintains $12 target

google.com·22w

Inflammation Fuels Blood Cancer Progression - EMJ

google.com·22w

How the ASH Clinical Practice Guidelines Aim to Improve <b>Myelofibrosis</b> Management

google.com·22w

Log in to enable infinite scrolling